How Does Berberine Interact With Other Medications?
Kobi NathanShare
Drug metabolism is the process your body uses to break down medicines so they can be used or removed.
Most of this happens in the liver.
A major group of proteins that help with this process are called cytochrome P450 enzymes (often shortened to CYP450).
These enzymes act like tiny machines that chemically change drugs into forms the body can use or get rid of.
Here’s how they work in simple terms:
When you take a drug, CYP450 enzymes help transform it into a more water-soluble form.
This helps your body either use it effectively or safely flush it out through urine or bile.
There are many types of CYP450 enzymes.
The most important ones for drug metabolism include CYP3A4 (handles about half of all drugs), CYP2D6, CYP2C9, CYP2C19, CYP1A2.
Why it matters:
- Some people have more or less active forms of these enzymes due to genetics.
- Some drugs can block or boost these enzymes, affecting how fast other drugs are broken down.
- If a drug is broken down too slowly, it can build up and cause side effects. If it's broken down too quickly, it might not work well.
To understand the seriousness of these interactions, read my case report on my patient here.
So, CYP450 enzymes play a key role in how drugs work and how safe they are in your body.
P-glycoprotein (P-gp) is a type of protein found in the cells of your body, especially in places like the intestines, liver, kidneys, and brain. It acts like a pump that moves certain substances—like drugs—out of your cells.
Here’s how it works in simple terms:
When you take medicine, P-gp can limit how much of it gets absorbed into your body by pumping it back into the intestines.
In the brain, it helps protect you from toxins by pumping drugs out of brain cells.
In the liver and kidneys, it helps remove drugs from your body through bile or urine.
Why it's important:
P-gp affects how much of a drug gets into your bloodstream and how long it stays in your body.
Some drugs can block or increase P-gp activity, which can change how other drugs work.
People with differences in their P-gp levels (due to genetics or health conditions) may respond differently to certain medications.
In short, P-glycoprotein helps control how drugs move through your body—and it plays a big role in drug effectiveness and safety.
AMP-activated protein kinase (AMPK) activation is like your body’s “energy helper.”
Imagine your cells are like tiny machines that need energy to work.
When they run low on energy, AMPK turns on like an emergency switch. It tells the cell to:
- Make more energy by burning fat and sugar
- Stop using energy on things that aren’t urgent
So, AMPK helps your body save and make energy when it’s needed—like during exercise or when you haven’t eaten in a while.
Myopathy is a medical term that means muscle disease.
It happens when the muscles don't work properly because the muscle fibers are damaged or weak.
People with myopathy might feel:
- Muscle weakness
- Tired muscles
- Trouble walking, lifting, or doing everyday activities
It can be caused by things like genetics, medications, infections, or autoimmune diseases.
- Pharmacokinetic of Berberine, the Main Constituent of Berberis Vulgaris L.: A Comprehensive Review. Khoshandam A, Imenshahidi M, Hosseinzadeh H. Phytotherapy Research : PTR. 2022;36(11):4063-4079. doi:10.1002/ptr.7589.
- The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Guo J, Chen H, Zhang X, et al. Oxidative Medicine and Cellular Longevity. 2021;2021:2074610. doi:10.1155/2021/2074610.
- Berberine: Pharmacological Features in Health, Disease and Aging. Gasmi A, Asghar F, Zafar S, et al. Current Medicinal Chemistry. 2024;31(10):1214-1234. doi:10.2174/0929867330666230207112539.
- Berberine, a Plant Alkaloid With Lipid- And Glucose-Lowering Properties: From In vitro Evidence to Clinical Studies. Pirillo A, Catapano AL. Atherosclerosis. 2015;243(2):449-61. doi:10.1016/j.atherosclerosis.2015.09.032.
- Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends. Behl T, Singh S, Sharma N, et al. Molecules (Basel, Switzerland). 2022;27(12):3705. doi:10.3390/molecules27123705.